Books > Social sciences > Politics & government > Central government > Central government policies
|
Buy Now
Overdose - How Excessive Government Regulation Stifles Pharmaceutical Innovation (Paperback)
Loot Price: R1,425
Discovery Miles 14 250
|
|
Overdose - How Excessive Government Regulation Stifles Pharmaceutical Innovation (Paperback)
Expected to ship within 10 - 15 working days
|
An analysis of how we regulate the pharmaceutical industry: are we
protecting patients or blocking the development of useful new
drugs? This book is the first to offer a comprehensive examination
of the pharmaceutical industry by following the tortuous course of
a new drug as it progresses from early development to final
delivery. Richard A. Epstein looks closely at the regulatory
framework that surrounds all aspects of making pharmaceutical
products today, and he assesses which current legal and regulatory
practices make sense and which have gone awry. While critics of
pharmaceutical companies call for ever more stringent controls on
virtually every aspect of drug development and approval, Epstein
cautions that the effect of such an approach will be to stifle
pharmaceutical innovation and slow the delivery of beneficial
treatments to the patients who need them. The author considers an
array of challenges that confront the industry--conflicts of
interest among government, academe, and the drug companies;
intellectual property rights that govern patents; FDA regulation;
pricing disputes; marketing practices; and liability issues,
including those brought to light in the recent VIOXX case. Epstein
argues that to ensure the continuing creativity, efficiency, and
success of the pharmaceutical industry, the best system will
feature strong property rights and clearly enforceable contracts,
with minimal regulatory and judicial interference.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.